1,166
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Low serum vitamin D level associated with incident advanced liver disease in the general population – a prospective study

ORCID Icon, , ORCID Icon, , , , , , ORCID Icon, & show all
Pages 299-303 | Received 14 Oct 2020, Accepted 04 Jan 2021, Published online: 21 Jan 2021

References

  • Elangovan H, Chahal S, Gunton JE. Vitamin D in liver disease: current evidence and potential directions. Biochim Biophys Acta Mol Basis Dis. 2017;1863(4):907–916.
  • Anty R, Canivet CM, Patouraux S, et al. Severe vitamin D deficiency may be an additional cofactor for the occurrence of alcoholic steatohepatitis. Alcohol Clin Exp Res. 2015;39(6):1027–1033.
  • Savic Z, Vracaric V, Milic N, et al. Vitamin D supplementation in patients with alcoholic liver cirrhosis: a prospective study. Minerva Med. 2018;109:352–357.
  • Kubesch A, Quenstedt L, Saleh M, et al. Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: a prospective cohort study. PLoS One. 2018;13(11):e0207162.
  • Borodulin K, Tolonen H, Jousilahti P, et al. Cohort profile: the national FINRISK study. Int J Epidemiol. 2018;47(3):696–696.
  • Heistaro S. Methodology report: health 2000 Survey. Helsinki, Finland: Publications of the National Public Health Institute; 2008.
  • Aberg F, Helenius-Hietala J, Puukka P, et al. Binge drinking and the risk of liver events: a population-based cohort study. Liver Int. 2017;37(9):1373–1381.
  • Pukkala E. Biobanks and registers in epidemiologic research on cancer. Methods Mol Biol. 2011;675:127–164.
  • Sund R. Quality of the Finnish hospital discharge register: a systematic review. Scand J Public Health. 2012;40(6):505–515.
  • Vogt S, Wahl S, Kettunen J, et al. Characterization of the metabolic profile associated with serum 25-hydroxyvitamin D: a cross-sectional analysis in population-based data. Int J Epidemiol. 2016;45(5):1469–1481.
  • Jaaskelainen T, Knekt P, Marniemi J, et al. Vitamin D status is associated with sociodemographic factors, lifestyle and metabolic health. Eur J Nutr. 2013;52:513–525.
  • Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–58.
  • Skaaby T, Husemoen LL, Borglykke A, et al. Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study. Endocrine. 2014;47(1):213–220.
  • Wu DB, Wang ML, Chen EQ, et al. New insights into the role of vitamin D in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2018;12(3):287–294.
  • Naderpoor N, Mousa A, Fernanda Gomez Arango L, et al. Effect of vitamin D supplementation on faecal microbiota: a randomised clinical trial. Nutrients. 2019;11(12):2888.
  • Mansouri L, Lundwall K, Moshfegh A, et al. Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial. BMC Nephrol. 2017;18(1):161–017.
  • Salekzamani S, Mehralizadeh H, Ghezel A, et al. Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial. J Endocrinol Invest. 2016;39(11):1303–1313.
  • Hariri M, Zohdi S. Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials. Int J Prev Med. 2019;10(14):14–21.
  • Bjelakovic G, Nikolova D, Bjelakovic M, et al. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017;(11):CD011564.